3 ms·
Stockholders are global, there is no disproportionate gain for Europeans. Novo trades on an American stock market, and Americans (whoever they may be) are reap
by lotsofpulp 2y ago
Stockholders are global, there is no disproportionate gain for Europeans. Novo trades on an American stock market, and Americans (whoever they may be) are reaping just as much of a benefit from Novo as they would from Eli/Pfizer/etc.